Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer (Q46082254)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer |
scientific article |
Statements
1 reference
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer (English)
1 reference
John D Hainsworth
1 reference
Denise A Yardley
1 reference
Jeffrey R Infante
1 reference
Howard A Burris
1 reference
F Anthony Greco
1 reference
Cindy P Farley
1 reference
Charles Webb
1 reference
David R Spigel
1 reference
1 February 2009
1 reference
1 reference
9
1 reference
1
1 reference
23-28
1 reference
Identifiers
1 reference
1 reference